Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TB vaccines: progress and problems.

P Andersen1

  • 1Dept of TB Immunology, Statens Seruminstitut, 5 Artillerivej, DK-2300 S, Copenhagen, Denmark. pa@ssi.dk

Trends in Immunology
|April 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetic hydrogel particles improve nanopore sequencing of SARS-CoV-2 and other respiratory viruses.

Scientific reports·2023
Same author

Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress.

The journal of prevention of Alzheimer's disease·2022
Same author

Hydrogel particles improve detection of SARS-CoV-2 RNA from multiple sample types.

Scientific reports·2020
Same author

Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination.

Scientific reports·2020
Same author

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis.

Frontiers in neuroscience·2020
Same author

Cosmological Constraints from Multiple Probes in the Dark Energy Survey.

Physical review letters·2019
Same journal

IL-33 scripts cancer immunity.

Trends in immunology·2026
Same journal

Mitochondrial Ca<sup>2+</sup> signaling: A metabolic rheostat defining tumor and immune cell fate.

Trends in immunology·2026
Same journal

Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations.

Trends in immunology·2026
Same journal

Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.

Trends in immunology·2026
Same journal

Metabolic regulatory nodes of the inflammasome and inflammatory cell death.

Trends in immunology·2026
Same journal

Parental leave in immunology - 6.

Trends in immunology·2026
See all related articles

Tuberculosis (TB) vaccines face challenges due to drug-resistant Mycobacterium tuberculosis and HIV. Understanding the failure of the current BCG vaccine is crucial for developing effective new TB vaccines.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Tuberculosis remains a leading global infectious killer, exacerbated by HIV and multidrug-resistant strains.
  • The current Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine shows limited efficacy in recent field trials.
  • Developing improved tuberculosis vaccines is a critical global health priority.

Purpose of the Study:

  • To analyze the reasons behind the insufficient efficacy of the BCG vaccine.
  • To explore hypotheses explaining BCG vaccine failure in tuberculosis prevention.
  • To inform the rational design of next-generation tuberculosis vaccines.

Main Methods:

  • Review of existing literature on BCG vaccine performance.
  • Analysis of immunological and epidemiological factors potentially affecting BCG efficacy.

Related Experiment Videos

  • Discussion of various hypotheses proposed for BCG failure.

    • Main Results:

    • BCG's variable protection against different forms of tuberculosis and across diverse populations is noted.
    • Factors such as prior exposure to environmental mycobacteria and genetic differences may influence BCG effectiveness.
    • Specific mechanisms of BCG-induced immunity and its limitations are debated.

    Conclusions:

    • Understanding BCG's shortcomings is essential for advancing tuberculosis vaccine development.
    • Future vaccines require novel strategies to overcome the limitations of BCG.
    • Targeted research is needed to address the complex challenges in TB vaccine design.